Abstract
Over the past few years our understanding of the importance of
adaptive immunity in acute coronary syndromes (ACS) has considerably
increased. Profound abnormalities have been observed in specific subsets of CD4+T cells, including type 1 helper T (Th1) cells,CD4+CD28nullT cells, and naturally occurring regulatory T cells (Treg cells).
Recently a new lineage of CD4+T cells, type 17 helper T (Th17) cells producing the signature cytokines interleukin (IL)-17, IL-21, and IL-22, has been identified. This has fundamentally changed the Th1/Th2 dichotomy paradigm.
| Original language | English |
|---|---|
| Pages (from-to) | 556-559 |
| Number of pages | 4 |
| Journal | European Heart Journal |
| Volume | 34 |
| DOIs | |
| Publication status | Published - 2013 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Acute Coronary Syndromes
- Atherosclerosis
- Immune system
- Interleukin-17
Fingerprint
Dive into the research topics of 'Interleukin-17 in atherosclerosis and cardiovascular disease: the good, the bad, and the unknown'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver